TNIK and cancer: Overall, our findings provide insight into the immunogenic nature of TNIK inhibition in Wnt-addicted cancers, which can motivate future clinical trials, especially with FDA-approved TNIKi, such as mebendazole, in combination with checkpoint inhibitors and/or other immunotherapies.